Home › Companies › Utah Medical Products, Inc. › 2025-2026

Utah Medical Products, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

  • 5Reported items
  • 157Asset managers
  • 660Fund votes
  • 2026-05-01Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Utah Medical Products, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Utah Medical Products, Inc. 2025-2026 meeting

Each item below shows how the 157 asset managers that disclosed a Utah Medical Products, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Utah Medical Products, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To hold an advisory vote on the Company's executive compensation program.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 117 asset managers below cast 99.8% of the shares they voted on this item FOR (1,313,794 for, 2,380 against).

FOR: 1,313,794 (99.8%)AGAINST: 2,380 (0.2%)NOT VOTED: 35 (0.0%)
Largest asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard175,4880 00For
BlackRock156,3240 00For
Renaissance139,7990 00For
GEODE CAPITAL MANAGEMENT, LLC117,5770 00For
Fidelity110,2960 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC83,4610 00For
Dimensional66,4380 00For
State Street51,67645 00For
T. Rowe Price33,7210 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC29,4630 00For
Cardinal Capital Management25,7400 00For
Northern Trust22,6680 00For
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
Huber Capital Management LLC18,3200 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
SEGALL BRYANT & HAMILL, LLC16,0210 00For
Newton Investment Management North America, LLC15,7000 00For
American Century14,5260 00For
LPL Financial LLC11,6380 00For
O'SHAUGHNESSY ASSET MANAGEMENT, LLC9,9710 00For
WisdomTree9,4390 00For
MELLON INVESTMENTS Corp9,3000 00For
RBC Capital Markets, LLC8,7220 00For
Prudential/PGIM8,4970 00For

Showing the 25 largest of 117 asset managers. See all 117 in the interactive database.

2. To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: Ernst G. Hoyer

DIRECTOR ELECTIONS

Combines 5 wordings of this item as funds reported it.

100% fund support · no official result

FOR 47.6%ABSTAIN 52.4%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (355,798 for, 0 against).

FOR: 355,798 (47.6%)ABSTAIN: 390,937 (52.4%)
Largest asset managers voting on “To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust00 169,7240Abstain
Vanguard153,8670 740For
Fidelity00 107,5450Abstain
BlackRock89,0240 00For
Dimensional00 48,2420Abstain
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST00 14,6020Abstain
Charles Schwab00 10,5320Abstain
WisdomTree00 9,4390Abstain
Prudential/PGIM8,0000 4970For
Equitable5,1150 3,2500For
American Century7,2630 00For
Columbia Threadneedle00 7,1000Abstain
Empower6,5000 00For
TIAA00 5,6190Abstain
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust00 3,2270Abstain
Invesco3,1220 00For
Series Portfolios Trust00 3,1000Abstain
Goldman Sachs2,7150 00For
Lincoln Financial00 1,9850Abstain

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

3. To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: James H. Beeson

DIRECTOR ELECTIONS

Combines 5 wordings of this item as funds reported it.

100% fund support · no official result

FOR 69%ABSTAIN 31%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (514,264 for, 0 against).

FOR: 514,264 (68.9%)ABSTAIN: 232,471 (31.1%)
Largest asset managers voting on “To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust00 169,7240Abstain
Vanguard153,9400 10For
Fidelity107,5450 00For
BlackRock89,0240 00For
Dimensional00 48,2420Abstain
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
Charles Schwab10,5320 00For
WisdomTree9,4390 00For
Prudential/PGIM8,0000 4970For
Equitable5,1150 3,2500For
American Century7,2630 00For
Columbia Threadneedle7,1000 00For
Empower6,5000 00For
TIAA00 5,6190Abstain
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust3,2270 00For
Invesco3,1220 00For
Series Portfolios Trust3,1000 00For
Goldman Sachs2,7150 00For
Lincoln Financial00 1,9850Abstain

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

4. To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2026; and

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (740,235 for, 0 against).

FOR: 740,235 (100.0%)
Largest asset managers voting on “To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year e” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Datum One Series Trust169,7240 00For
Vanguard153,9410 00For
Fidelity107,5450 00For
BlackRock89,0240 00For
Dimensional48,2420 00For
HOTCHKIS & WILEY FUNDS /DE/21,8000 00For
ADVISORS SERIES TRUST17,5950 00For
Principal16,2870 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
Charles Schwab10,5320 00For
WisdomTree9,4390 00For
Prudential/PGIM8,4970 00For
Equitable8,3650 00For
American Century7,2630 00For
Columbia Threadneedle7,1000 00For
TIAA5,6190 00For
QUANTITATIVE MASTER SERIES LLC5,0350 00For
BRIDGEWAY FUNDS INC5,0000 00For
EA Series Trust3,2780 00For
Northern Trust3,2270 00For
Invesco3,1220 00For
Series Portfolios Trust3,1000 00For
Goldman Sachs2,7150 00For
Lincoln Financial1,9850 00For
AIG/SunAmerica1,3890 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

5. To approve, by advisory vote, the Company's executive compensation program.

SECTION 14A SAY-ON-PAY VOTES

99.5% fund support · no official result

FOR 99.5%

The 40 asset managers below cast 99.5% of the shares they voted on this item FOR (518,238 for, 2,252 against).

FOR: 518,238 (99.5%)AGAINST: 2,252 (0.4%)NOT VOTED: 135 (0.0%)
Largest asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BRANDES INVESTMENT PARTNERS, LP215,9680 00For
Datum One Series Trust169,7240 00For
RICE HALL JAMES & ASSOCIATES, LLC61,4570 00For
Charles Schwab21,7860 00For
CLEARWATER INVESTMENT TRUST14,6020 00For
LSV ASSET MANAGEMENT7,7001,229 00For
Penobscot Investment Management Company, Inc.4,0000 00For
Metis Global Partners, LLC3,4470 00For
Acuitas Investments, LLC3,1000 00For
Series Portfolios Trust3,1000 00For
MACKENZIE FINANCIAL CORP2,0400 00For
SEI1,8330 00For
NEW YORK STATE COMMON RETIREMENT FUND1,4290 00For
Global X1,3770 00For
WASHINGTON STATE INVESTMENT BOARD1,1440 00For
Universal-Investment-Gesellschaft mbH1,0000 00For
Neuberger Berman7320 00For
Summit Trail Advisors, LLC6540 00For
NEW COVENANT FUNDS5150 00For
BANK OF AMERICA NA4660 00For
XPONANCE LLC21419 00Against
Nationwide4220 00For
Vanguard3700 00For
Russell Investments3000 00For
Prudential/PGIM2600 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

Largest Utah Medical Products, Inc. shareholders voting in 2025-2026

Ranked by the number of Utah Medical Products, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 3,185,025 shares outstanding at the time of that meeting.

Top Utah Medical Products, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 5.51%
2BlackRock 4.91%
3Renaissance 4.39%
4GEODE CAPITAL MANAGEMENT, LLC 3.69%
5Fidelity 3.46%
6HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.62%
7Dimensional 2.09%
8State Street 1.62%
9T. Rowe Price 1.06%
10PARAMETRIC PORTFOLIO ASSOCIATES LLC 0.93%

Reported Utah Medical Products, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Utah Medical Products, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BRANDES INVESTMENT PARTNERS, LP 14.92% 13G
Dimensional Fund Advisors 6.21% 13F
BlackRock 5.89% 13F
Renaissance Technologies 5.78% 13F
Vanguard Group 5.52% 13F
Geode Capital 3.77% 13F
State Street 2.02% 13F
Morgan Stanley 1.37% 13F
BNY Mellon 1.01% 13F
Northern Trust 0.95% 13F

Percentages above are of 3,185,025 shares outstanding, as reported by Utah Medical Products, Inc. on its Form 10-K dated 2026-03-26 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Utah Medical Products, Inc.’s 10-K dated 2026-03-26. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Utah Medical Products, Inc.'s shareholder meeting held 2026-05-01, in the 2025-2026 proxy season, 157 asset managers reported how they voted in their SEC Form N-PX filings, covering 660 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To hold an advisory vote on the Company's executive compensation program. — the reporting funds cast 99.8% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Utah Medical Products, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).